Larson Financial Group LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 250 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
Larson Financial Group LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,460
-35.4%
1,2000.0%0.00%0.0%
Q2 2023$8,448
+15.2%
1,2000.0%0.00%0.0%
Q1 2023$7,332
-4.4%
1,2000.0%0.00%0.0%
Q4 2022$7,668
-30.3%
1,2000.0%0.00%
-50.0%
Q3 2022$11,000
-15.4%
1,2000.0%0.00%0.0%
Q2 2022$13,000
-35.0%
1,200
-14.3%
0.00%
-33.3%
Q1 2022$20,0000.0%1,400
+75.0%
0.00%
-25.0%
Q3 2021$20,000
-4.8%
8000.0%0.00%
-20.0%
Q2 2021$21,000
-16.0%
8000.0%0.01%
-28.6%
Q1 2021$25,000
-32.4%
8000.0%0.01%
-46.2%
Q4 2020$37,000
+42.3%
8000.0%0.01%
+18.2%
Q3 2020$26,0008000.01%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,876,600$127,618,00011.48%
Fairmount Funds Management LLC 596,890$19,650,0008.32%
Ghost Tree Capital, LLC 575,000$18,929,0005.47%
Perceptive Advisors 10,085,632$332,019,0004.85%
Avoro Capital Advisors LLC 9,536,039$313,926,0004.46%
FRAZIER MANAGEMENT LLC 1,312,999$43,224,0003.88%
ACUTA CAPITAL PARTNERS, LLC 315,000$10,370,0002.82%
Orbimed Advisors 6,645,100$218,757,0002.75%
QVT Financial LP 572,971$18,862,0002.30%
Prosight Management, LP 120,606$3,970,0001.89%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders